{
    "case_number": "CAC-ADREU-003748",
    "time_of_filling": null,
    "domain_names": [],
    "case_administrator": null,
    "complainant": [],
    "complainant_representative": null,
    "respondent": [],
    "respondent_representative": null,
    "factual_background": "According to Complainant it acts as licensee within the European Union of certain intellectual property rights owned by various US companies. The license agreements relate to Benelux or Community trademarks. The trademarks are identical to the 12 Domain Names which were obtained by Respondent during the so-called Land Rush period and which are the subject of the Complaint.",
    "other_legal_proceedings": "To the knowledge of the Panel, there are no other legal proceedings pending or decided that relate to the disputed domain names.",
    "discussion_and_findings": "In the unanimous opinion of the Panel, in the event a Respondent explicitly agrees with a transfer of the Domain Names as requested by Complainant, the Panel is able to order the requested relief. If a Complainant requests a transfer of the Domain Names and such request is agreed to Respondent, the Panel recognizes the requests of the two parties. The Panel does not make any other findings of fact, but will make the only order that is appropriate in the circumstances which is an order for the transfer of the Domain Name to Complainant.\r\nFor the avoidance of doubt, the Panel does not decide whether the stipulation by Respondent that it agrees with the requested transfer can be considered a settlement within the meaning of Paragraph (4a) of the ADR Rules, nor does it decide the question whether the registration by Respondent of the Domain Names was without rights or legitimate interest or made in bad faith.",
    "decision": "For all the foregoing reasons, in accordance with Paragraphs B12 (b) and (c) of the Rules, the Panel orders that the domain name ENDOTHIL, FORMULA9, HYLEXIN, IDEBENOL, KLEINBECKER, LIPEXPLOSION, OXYDRENE, RELACORE, RETIVA, SOVAGE, STRIVECTIN, ZANTREX be transferred to the Complainant.",
    "panelists": [
        null
    ],
    "date_of_panel_decision": "2007-02-13 00:00:00",
    "informal_english_translation": "In the unanimous opinion of the Panel, in the event a Respondent explicitly agrees with a transfer of the Domain Names as requested by Complainant, the Panel is able to order the requested relief. If a Complainant requests a transfer of the Domain Names and such request is agreed to Respondent, the Panel recognizes the requests of the two parties. The Panel does not make any other findings of fact, but will make the only order that is appropriate in the circumstances which is an order for the transfer of the Domain Name to Complainant.\r\nFor the avoidance of doubt, the Panel does not decide whether the stipulation by Respondent that it agrees with the requested transfer can be considered a settlement within the meaning of Paragraph (4a) of the ADR Rules, nor does it decide the question whether the registration by Respondent of the Domain Names was without rights or legitimate interest or made in bad faith.",
    "decision_domains": [],
    "panelist": null,
    "panellists_text": null
}